Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatment-resistant obsessive-compulsive disorder
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
In open trials, 1-Hz repetitive transcranial magnetic stimulation (rTMS) to the supplementary motor area (SMA) improved symptoms and normalized cortical hyper-excitability of patients with obsessive-compulsive disorder (OCD). Here we present the results of a randomized sham-controlled double-blind study. Medication-resistant OCD patients (n=21) were assigned 4 wk either active or sham rTMS to the SMA bilaterally. rTMS parameters consisted of 1200 pulses/d, at 1 Hz and 100% of motor threshold (MT). Eighteen patients completed the study. Response to treatment was defined as a > or = 25% decrease on the Yale-Brown Obsessive Compulsive Scale (YBOCS). Non-responders to sham and responders to active or sham rTMS were offered four additional weeks of open active rTMS. After 4 wk, the response rate in the completer sample was 67% (6/9) with active and 22% (2/9) with sham rTMS. At 4 wk, patients receiving active rTMS showed on average a 25% reduction in the YBOCS compared to a 12% reduction in those receiving sham. In those who received 8-wk active rTMS, OCD symptoms improved from 28.2+/-5.8 to 14.5+/-3.6. In patients randomized to active rTMS, MT measures on the right hemisphere increased significantly over time. At the end of 4-wk rTMS the abnormal hemispheric laterality found in the group randomized to active rTMS normalized. The results of the first randomized sham-controlled trial of SMA stimulation in the treatment of resistant OCD support further investigation into the potential therapeutic applications of rTMS in this disabling condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on these findings, multiple studies have applied low frequency TMS in SMA to reverse its hyperactivity with promising results, including two sham-controlled trials 135,136.”
From DISSECTING OCD CIRCUITS: FROM ANIMAL MODELS TO TARGETED TREATMENTS: Review: Dissecting OCD Circuits: Animals to Treatments (2015) · cites this paper as [136]
In the citing paper
“Cerebral-cerebellum connectivity disruption has been reported in several psychiatric disorders, including psychotic disorders(70), depressive disorder(71), autism(72) and attention-deficit/hyperactivity disorder(73).”
From Functional disruption of cerebello-thalamo-cortical networks in obsessive-compulsive disorder (2020) · cites this paper as [70]
Citations
Cites
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712 · cited 1×
“…current episode duration of at least a year, have residual OCD symptoms [defined as a total YaleBrown Obsessive Compulsive Scale (YBOCS) score of o16] (Goodman et al. 1989a, b) despite treatment with an adequate trial of a serotonin re-uptake inhibitor (SRI) and cognitive behaviour therapy (CBT).”
BackgroundCochrane Database of Systematic Reviews
(2008) · Encyclopedia of Public Health · doi:10.1007/978-1-4020-5614-7_436 · Cited by 4,527
Rossini, P. M., Barker, A. T., Berardelli, A., Caramia, M. D., Caruso, G., Cracco, R. Q., Dimitrijević, M. R., Hallett, M., Katayama, Y., Lücking, C. H., et al. (1994) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(94)90029-9 · Cited by 3,030
The Yale-Brown Obsessive Compulsive Scale: II. Validity
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110054008 · Cited by 2,799
The Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency
Kim, S. W., Dysken, M. W., Pheley, A. M., & Hoover, K. M. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90039-6 · Cited by 2,359
Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation
Chen, R., Classen, J., Gerloff, C., Celnik, P., Wassermann, E. M., Hallett, M., & Cohen, L. G. (1997) · Neurology · doi:10.1212/wnl.48.5.1398 · Cited by 2,128 · cited 1×
“Given the evidence for deficient inhibition in OCD, the use of low-frequency rTMS, which has been reported to be inhibitory on motor cortex excitability (Chen et al. 1997), may be a fruitful avenue to explore as a putative treatment.”
BackgroundMenzies, L., Chamberlain, S. R., Laird, A. R., Thelen, S. M., Sahakian, B. J., & Bullmore, E. T. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.09.005 · Cited by 1,190 · cited 2×
“: 212-543-6081 Fax : 212-543-4284 Email : AM2518@columbia.edu by guest on O ctober 7, 2016 http://ijnp.oxfordjournals.org/ D ow nloaded from (Menzies et al. 2008).”
BackgroundPractice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
(2008) · APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches · doi:10.1176/appi.books.9780890423363.149114 · Cited by 1,028 · cited 1×
“An adequte SRI trial was defined as treatment for at least 12 wk on the SRI, that meets or exceeds recommended dosage level for OCD (Koran et al. 2007).”
MethodSelf-citationAmerican Journal of Psychiatry
Ketzenberger, K. E. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced0109 · Cited by 844
Research works printed but not linked: 3
- First, 1997, Structured Clinical Interview for DSM-IV Axis I Disorders – Patient Edition (SCID-I/P, Version 2.0, 4/97 Revision)
- 10.1109/IEMBS.2006.4397621 · doi:10.1109/iembs.2006.4397621
- Prasko, 2006, Neuroendocrinology Letters, 27, 327
Cited by
Lefaucheur, J.-P., Aleman, A., Baeken, C., Benninger, D. H., Brunelin, J., Di Lazzaro, V., Filipović, S. R., Grefkes, C., Hasan, A., Hummel, F. C., et al. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.11.002 · Cited by 2,382
Self-citationLefaucheur, J.-P., André-Obadia, N., Antal, A., Ayache, S. S., Baeken, C., Benninger, D. H., Cantello, R. M., Cincotta, M., de Carvalho, M., De Ridder, D., et al. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.05.021 · Cited by 2,119
Self-citationKatzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“However, results of sham-controlled trials are conflicting, with some trials finding significant improvements [827,828] and others concluding that rTMS was ineffective for treatment-resistant OCD (Level 1, conflicting) [829-831].”
ResultMcClintock, S. M., Reti, I. M., Carpenter, L. L., McDonald, W. M., Dubin, M., Taylor, S. F., Cook, I. A., O’Reardon, J., Husain, M. M., Wall, C., et al. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16cs10905 · Cited by 693
Self-citationPeters, S. K., Dunlop, K., & Downar, J. (2016) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2016.00104 · Cited by 611
“, 2015), and stimulation of medial SN nodes in the dACC/dmPFC and adjacent pre-supplementary motor area have also shown promising effects in OCD (Mantovani et al., 2010; Dunlop et al., 2015a) and PTSD (Isserles et al.”
BackgroundMethod
Metadata
- Authors
- Mantovani, A., Simpson, H. B., Fallon, B. A., Rossi, S., & Lisanby, S. H.
- Affiliations
- University of Siena (IT)
- New York State Psychiatric Institute (US)
- Corresponding author
- Mantovani, Antonio
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-08-20
- Volume
- 13
- Issue
- 02
- Pages
- 217
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2149020833
- Cited by
- 281
- References
- 32
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 18 · 2023: 16 · 2022: 24 · 2021: 18 · 2020: 19 · 2019: 17 · 2018: 16 · 2017: 11 · 2016: 19 · 2015: 28 · 2014: 16 · 2013: 17 · 2012: 13
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Use Siena air (University of Siena) (submittedVersion)
- Columbia Academic Commons (Columbia University)
- Funders
- Department of Psychiatry, Columbia University
- National Institute of Mental Health (K24MH091555)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- obsessive-compulsive disorder, treatment-resistant OCD, repetitive transcranial magnetic stimulation, supplementary motor area, cortical excitability, hemispheric lateralization, Yale-Brown Obsessive Compulsive Scale, non-pharmacological treatment
- MeSH terms
- Adult, Double-Blind Method, Drug Resistance, Electromyography, Female, Humans, Functional Laterality, Male, Motor Cortex, Obsessive-Compulsive Disorder, Psychiatric Status Rating Scales, Severity of Illness Index, Time Factors, Treatment Outcome, Transcranial Magnetic Stimulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatment-resistant obsessive-compulsive disorder. https://app.cochat.ai/papers/10.1017/s1461145709990435
- The paper
- Mantovani, A., Simpson, H. B., Fallon, B. A., Rossi, S., & Lisanby, S. H. (2010). Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatment-resistant obsessive-compulsive disorder. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145709990435
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.